NCT04468139

Brief Summary

There are currently no antiviral drugs with proven efficacy nor are there vaccines for its prevention. Unfortunately, the scientific community has little knowledge of the molecular details of SARS-CoV-2 infection. The drugs we are chosen are used as clinical trials for antiviral and there is no proven guide for specificity and effectiveness against the virus so the results are different Now the clinical trials and research authorities are work speedily to target the most proven treatment for the virus so anything is infantile until now. the covid-19 with time be more explained by scientists it is steroid response disease and cause thromosis and cytokine storm , the aim of the study to inhibit viral replication and decrease the severity of the disease as antiviral and anticytokine storm , antithrombosis Zinc is a mineral element needed to regulate adaptive immune cells' functions. Higher level of intracellular zinc showed to increase intracellular pH; which affect on RNA-dependent RNA polymerase and decrease replication mechanism of RNA viruses. Therefore, drugs that described as zinc ionophores could be used with zinc supplement to act as antiviral against many RNA viruses including SARS-CoV-2 Quercetin is natural compound act as zinc ionophore to cause zinc influx intracellular. Quercetin is a safe natural anti-oxidant and anti-inflammatory polyphenolic compound that found in various natural sources include onion, red grapes, honey and citrus fruits. It was shown that quercetin has the ability to chelate zinc ions and act as zinc ionophore. Therefore, quercetin could have antiviral activity against many RNA viruses . Quercetin, a flavonoid found in fruits and vegetables, has unique biological properties that may improve mental/physical performance and reduce infection risk ; These properties form the basis for potential benefits to overall health and disease resistance, including anti-carcinogenic, anti-inflammatory, antiviral, antioxidant, and psychostimulant activities, as well as the ability to inhibit lipid peroxidation, platelet aggregation and capillary permeability, and to stimulate mitochondrial biogenesis .There are various studies that report the immunomodulatory effect of bromelain . Bromelain activates natural killer cells and augments the production of granulocyte-macrophage-colony stimulating factor, IL-2, IL-6 and decreases the activation of Thelper cells. Thus, bromelain decreases the majority of inflammatory mediators and has demonstrated a significant role as an anti-inflammatory agent in various conditions Vitamin C is known as an essential anti-oxidant.,and enzymatic co-factor for physiological reactions such as hormone production, collagen synthesis and immune potentiation . Naturally, an insufficiency of vitamin C leads to severe injuries to multiple organs, especially to the heart and brain, since they are both highly aerobic organs that produce more oxygen radicals. In fact, studies of in vivo effect on vitamin C are difficult since most animals, except human and some primate, are capable of synthesizing vitamin C endogenously

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at below P25 for phase_4 covid19

Timeline
Completed

Started Jun 2020

Shorter than P25 for phase_4 covid19

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 20, 2020

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

July 5, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 13, 2020

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2020

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2020

Completed
Last Updated

July 13, 2020

Status Verified

July 1, 2020

Enrollment Period

1 month

First QC Date

July 5, 2020

Last Update Submit

July 9, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • days of stay at hospital after treatment and discharge

    speed the days of recovery and discharge from hospital

    28 days

  • serum zinc before and after treatment

    the level of serum zinc is very important especially at chronic diseases

    5-10 days

Secondary Outcomes (2)

  • questionnaire including parameters like BMI,,smoking , underling diseases, immunological treatment ,

    28 days

  • day of negative conversion for nasopharyngeal swab for rt-PCR FOR covid-19

    28 days

Study Arms (1)

Quercetin

EXPERIMENTAL

Quercetin 500 g of quercetin Quercetin will be administered orally once daily, in the morning before breakfast for 5-10 days or patient improves or discharged

Drug: QuercetinDietary Supplement: bromelainDrug: ZincDrug: Vitamin C

Interventions

Dietary Supplement: Quercetin Treatment a daily dose of quercetin (500 mg) will be taken orally by proven COVID-19 cases intervention

Quercetin
bromelainDIETARY_SUPPLEMENT

Dietary Supplement:Bromealin Treatment a daily dose of bromelain(500 mg) will be taken orally by proven COVID-19 cases intervention

Quercetin
ZincDRUG

zinc 50 mg orally daily dose will be taken orally by proven COVID-19 cases intervention

Quercetin

vitamin c 1000 mg orally daily by proven COVID-19 cases intervention

Quercetin

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • positive confirmed PCR covid-19
  • moderate to severe cases
  • obtained consent
  • must be able to swallow tablets

You may not qualify if:

  • Patients who live outside Saudia Arabia
  • Pregnant women: Current known pregnancy positive pregnancy test.
  • Lactating women.
  • Documented allergy to pineapple or to quercetin
  • Documented history of mental illnesses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ministry of health.First health cluster ,Riaydh

Riyadh, Saudi Arabia

RECRUITING

MeSH Terms

Conditions

COVID-19

Interventions

QuercetinBromelainsZincAscorbic Acid

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

FlavonolsFlavonoidsChromonesBenzopyransPyransHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingCysteine EndopeptidasesCysteine ProteasesPeptide HydrolasesHydrolasesEnzymesEnzymes and CoenzymesEndopeptidasesMetals, HeavyElementsInorganic ChemicalsTransition ElementsMetalsSugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydrates

Study Officials

  • Hiba Hamadelnil elsaeed

    Netherlands: Ministry of Health, Welfare and Sports

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director of mobile team tuberculosis ghubera, tuberculosis control program

Study Record Dates

First Submitted

July 5, 2020

First Posted

July 13, 2020

Study Start

June 20, 2020

Primary Completion

July 20, 2020

Study Completion

July 30, 2020

Last Updated

July 13, 2020

Record last verified: 2020-07

Locations